Unraveling Targets of Therapy in Bronchial Thermoplasty in Severe Asthma (TASMA) Extension Study

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Status: Active, not recruiting

Conditions: Severe Asthma

Study type: Observational

Funder types: Other

Identifiers

NCT02975284

NL53703.018.15

Details and patient eligibility

About

This study evaluates the longterm clinical outcomes, including safety and efficacy parameters after Bronchial Thermoplasty (BT) treatment over a period of 5 years. All patients included in de TASMA trial in the Netherlands will be asked to participate in the TASMA extension study.

Enrollment: 30 estimated patients

Sex: All

Ages: 18 to 65 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Subject participation in the TASMA study
• Ability and willingness to provide informed consent.
• Ability to comply with the study protocol

Exclusion criteria

• Subject participating in another clinical trial involving respiratory intervention which in the opinion of the investigator might interfere with the study.